Kyntra Bio (FRA:1FG0) Minority Interest: €19.10 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1FG0 Kyntra Bio Inc FRA:1FG0
53 GF Score
Price €6.25
GF Value €3.69
! 9 Warning Signs
View Full Analysis

What is Kyntra Bio Minority Interest?

Kyntra Bio FRA:1FG0 +3.31% 53 Minority Interest is €19.10 Mil as of Jun. 2026. GuruFocus rates FRA:1FG0 with a GF Score™ of 53/100 and a GF Value™ of €3.69. The stock has 9 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Kyntra Bio's minority interest for the quarter that ended in Jun. 2026 was €19.10 Mil.

Kyntra Bio Minority Interest Historical Data

* Premium members only.

The historical data trend for Kyntra Bio's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyntra Bio Minority Interest Chart

Kyntra Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.67 18.85 38.48 40.08 29.47

Kyntra Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.39 29.41 29.47 29.85 19.10
FRA:1FG0
53GF Score
Kyntra Bio Inc FRA:1FG0
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyntra Bio Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of €19.10 Mil mean?
Kyntra Bio (FRA:1FG0) has a Minority Interest of €19.10 Mil as of Jun. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Kyntra Bio.
Is Kyntra Bio's Minority Interest too high?
Kyntra Bio's current Minority Interest is €19.10 Mil. Overall, Kyntra Bio has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Kyntra Bio's Minority Interest compare to ACTU and PLRZ?
Kyntra Bio's Minority Interest of €19.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Biotechnology company?
A good Minority Interest depends on the Biotechnology industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Kyntra Bio. Kyntra Bio's current Minority Interest is €19.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyntra Bio stock overvalued right now?
Kyntra Bio (FRA:1FG0) has a current Minority Interest of €19.10 Mil. The stock's GF Value™ is €3.69, compared to a current price of €6.25 — trading 69.4% above its estimated fair value. The current Minority Interest is €19.10 Mil. Kyntra Bio's overall GF Score™ is 53/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Kyntra Bio (FRA:1FG0), the current Minority Interest is €19.10 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyntra Bio (FRA:1FG0) Overvalued in 2026?

Based on GuruFocus' analysis, Kyntra Bio stock appears to be overvalued. The current stock price of €6.25 is trading 69.4% above its estimated GF Value™ of €3.69.

Key valuation signals for FRA:1FG0:

  • Minority Interest: €19.10 Mil
  • GF Value™: €3.69 vs. price of €6.25 (69.4% above fair value)
  • GF Score™: 53/100 with 9 warning signs

No single metric tells the full story. See the FRA:1FG0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyntra Bio Business Description

Other Exchanges KYNB:USAKYNB:Mexico0IL8:UK
Address 350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94133
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
53GF Score

Get the complete analysis for FRA:1FG0

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€3.69
GF Value